Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Leiden University Medical Center
Massachusetts General Hospital
Delfi Diagnostics Inc.
Medipol University
Kayseri City Hospital
Navigation Sciences, Inc.
Hoffmann-La Roche
University of Alabama at Birmingham
Başakşehir Çam & Sakura City Hospital
Revolution Medicines, Inc.
Rigshospitalet, Denmark